Join to View Full Profile
8920 Wilshire BlvdSuite 330Beverly Hills, CA 90211
Phone+1 323-954-8084
Fax+1 323-587-9429
Dr. Karns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Adam Karns, MD, is an internal medicine specialist based in Beverly Hills, CA. He completed his medical residency in internal medicine at Kaiser Permanente Southern California from 1991 to 1994, after earning his medical degree from Chicago Medical School at Rosalind Franklin University. His publication record includes research on treatments for dyslipidemia and resistant hypertension, with notable studies published in respected journals like the Journal of Clinical Lipidology and Journal of Clinical Hypertension. Dr. Karns has been involved in clinical trials, specifically investigating the efficacy and safety of lorundrostat in hypertension. He received the CMS Meaningful Use Stage 1 Certification from Aprima EHR in 2013.
Education & Training
Kaiser Permanente Southern California (Los Angeles)Residency, Internal Medicine, 1993 - 1994- Kaiser Permanente Southern California (Los Angeles)Residency, Internal Medicine, 1991 - 1993
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1991
Certifications & Licensure
CA State Medical License 1992 - 2027
NV State Medical License 1994 - 1997
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Aprima, Aprima Medical Software, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension Start of enrollment: 2023 Nov 22
Roles: Contact
Publications & Presentations
PubMed
- 15 citationsAdd-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.Akshay S Desai, Adam D Karns, Jolita Badariene, Ahmad Aswad, Joel M Neutel
JAMA. 2025-07-01 - 43 citationsEffects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.Patrick M. Moriarty, Eli M. Roth, Adam Karns, Ping Ye, Shui-ping Zhao
Journal of Clinical Lipidology. 2014-11-01 - 2 citationsLeft Ventricular Hypertrophy andCardiac Function in Patients WithResistant HypertensionNorman E. Lepor
Reviews in Cardiovascular Medicine. 2013-03-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
